AIG
GSK icon

American International Group’s GSK GSK Stock Holding History

American International Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-43,255
Closed -$2.19M – 3626
2016
Q1 		$2.19M Buy
43,255
+3,342
+8% +$166K 0.01% 1083
2015
Q4 		$2.01M Buy
39,913
+1,147
+3% +$58.5K 0.01% 1099
2015
Q3 		$1.86M Sell
38,766
-4,230
-10% -$220K 0.01% 1113
2015
Q2 		$2.24M Buy
42,996
+1,026
+2% +$57.8K 0.01% 1088
2015
Q1 		$2.42M Buy
41,970
+4,815
+13% +$276K 0.01% 1080
2014
Q4 		$1.99M Sell
37,155
-1,572
-4% -$87.9K 0.01% 1131
2014
Q3 		$2.23M Buy
38,727
+10,837
+39% +$664K 0.01% 1070
2014
Q2 		$1.86M Buy
27,890
+8,541
+44% +$578K 0.01% 1173
2014
Q1 		$1.29M Buy
19,349
+1,975
+11% +$134K 0.01% 1348
2013
Q4 		$1.16M Buy
17,374
+1,892
+12% +$123K 0.01% 1377
2013
Q3 		$971K Buy
15,482
+3,274
+27% +$211K 0.01% 1434
2013
Q2 		$763K Buy
+12,208
New +$775K ﹤0.01% 1551

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

American International Group's GSK Position: Q2 2016 in Review

American International Group sold out of GSK (GSK) in Q2 2016, closing a stake of 43,255 shares — an estimated $2.19M sold.

American International Group first reported a position in GSK in Q2 2013 and held it in 12 quarters. The position peaked at $2.42M in Q1 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • American International Group reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 43,255 GSK shares in Q2 2016, an estimated $2.19M.
  • American International Group first reported a position in GSK in Q2 2013 and held it in 12 quarters.
  • American International Group's GSK position peaked at $2.42M in Q1 2015.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.